BACKGROUND: Combination antiretroviral therapy (ART) has been used for HIV-infected children in many Asian countries since 2002. This study describes survival outcomes among HIV-infected children in a multicenter regional cohort in Asia. PATIENTS AND METHODS: Retrospective and prospective data collected through March 2009 from children in 5 countries enrolled in TREAT Asia's Pediatric HIV Observational Database were analysed. Multivariate Cox proportional hazard models were used to assess factors associated with mortality in children who received ART. RESULTS: Among 2280 children, 1752 (77%) had received ART. During a median follow-up of 3.1 years after ART, 115 (6.6%) deaths occurred, giving a crude mortality rate of 1.9 per 100 child-years [95% confidence interval (CI): 1.6 to 2.4]. The mortality rate was highest in the first 3 months of ART (10.2 per 100 child-years; 95% CI: 7.5 to 13.7) and declined after 12 months (0.9 per 100 child-years; 95% CI: 0.7 to 1.3). Those with a low recent CD4 percentage, who started ART with lower baseline weight-for-age Z score, or with WHO clinical stage 4 had an increased risk of death. Of 528 (23%) children who never received ART, 36 (6.8%) died after presenting to care, giving a crude mortality rate of 4.1 per 100 child-years (95% CI: 3.0 to 5.7), with a lost-to-program rate of 31.5 per 100 child-years (95% CI: 28.0 to 35.5). CONCLUSIONS: The high mortality during the first 3 months of ART and in those with low CD4 percentage support the implementation of early diagnosis and ART initiation.
BACKGROUND: Combination antiretroviral therapy (ART) has been used for HIV-infectedchildren in many Asian countries since 2002. This study describes survival outcomes among HIV-infectedchildren in a multicenter regional cohort in Asia. PATIENTS AND METHODS: Retrospective and prospective data collected through March 2009 from children in 5 countries enrolled in TREAT Asia's Pediatric HIV Observational Database were analysed. Multivariate Cox proportional hazard models were used to assess factors associated with mortality in children who received ART. RESULTS: Among 2280 children, 1752 (77%) had received ART. During a median follow-up of 3.1 years after ART, 115 (6.6%) deaths occurred, giving a crude mortality rate of 1.9 per 100 child-years [95% confidence interval (CI): 1.6 to 2.4]. The mortality rate was highest in the first 3 months of ART (10.2 per 100 child-years; 95% CI: 7.5 to 13.7) and declined after 12 months (0.9 per 100 child-years; 95% CI: 0.7 to 1.3). Those with a low recent CD4 percentage, who started ART with lower baseline weight-for-age Z score, or with WHO clinical stage 4 had an increased risk of death. Of 528 (23%) children who never received ART, 36 (6.8%) died after presenting to care, giving a crude mortality rate of 4.1 per 100 child-years (95% CI: 3.0 to 5.7), with a lost-to-program rate of 31.5 per 100 child-years (95% CI: 28.0 to 35.5). CONCLUSIONS: The high mortality during the first 3 months of ART and in those with low CD4 percentage support the implementation of early diagnosis and ART initiation.
Authors: Delphine Sauvageot; Myrto Schaefer; David Olson; Mar Pujades-Rodriguez; Daniel P O'Brien Journal: Pediatrics Date: 2010-04-12 Impact factor: 7.124
Authors: Wasana Prasitsuebsai; Asha C Bowen; Joselyn Pang; Cees Hesp; Azar Kariminia; Annette H Sohn Journal: AIDS Patient Care STDS Date: 2010-02 Impact factor: 5.078
Authors: N Kumarasamy; Kartik K Venkatesh; Bella Devaleenol; S Poongulali; S N Mothi; Suniti Solomon Journal: J Trop Pediatr Date: 2008-10-01 Impact factor: 1.165
Authors: Dalton C Wamalwa; Elizabeth M Obimbo; Carey Farquhar; Barbra A Richardson; Dorothy A Mbori-Ngacha; Irene Inwani; Sara Benki-Nugent; Grace John-Stewart Journal: BMC Pediatr Date: 2010-05-18 Impact factor: 2.125
Authors: Andrea L Ciaranello; Yuchiao Chang; Andrea V Margulis; Adam Bernstein; Ingrid V Bassett; Elena Losina; Rochelle P Walensky Journal: Clin Infect Dis Date: 2009-12-15 Impact factor: 9.079
Authors: Louise C Ivers; Kimberly A Cullen; Kenneth A Freedberg; Steven Block; Jennifer Coates; Patrick Webb Journal: Clin Infect Dis Date: 2009-10-01 Impact factor: 9.079
Authors: Michael T Brady; James M Oleske; Paige L Williams; Carol Elgie; Lynne M Mofenson; Wayne M Dankner; Russell B Van Dyke Journal: J Acquir Immune Defic Syndr Date: 2010-01 Impact factor: 3.731
Authors: Linda Aurpibul; Torsak Bunupuradah; Sam Sophan; David Boettiger; Dewi K Wati; Lam V Nguyen; Vonthanak Saphonn; Rawiwan Hansudewechakul; Kulkanya Chokephaibulkit; Pagakrong Lumbiganon; Khanh H Truong; Viet C Do; Nagalingeswaran Kumarasamy; Nik K N Yusoff; Kamarul Razali; Nia Kurniati; Siew M Fong; Revathy Nallusamy; Annette H Sohn Journal: Pediatr Infect Dis J Date: 2015-06 Impact factor: 2.129